229 filings
Page 2 of 12
8-K
ammcay80d vpzdtr9c
25 Jul 22
Other Events
5:12pm
8-K
bhanmo 8x
23 Jun 22
Other Events
4:15pm
8-K
kkgcol62r 71ee3
8 Jun 22
Rigel Announces Top-line Results from FORWARD Phase 3 Clinical Trial of Fostamatinib in Patients with Warm Autoimmune Hemolytic Anemia
4:15pm
8-K
21iod586ue7txzzh
23 May 22
Departure of Directors or Certain Officers
4:52pm
8-K
k81 skrzywixk5
3 May 22
Rigel Reports First Quarter 2022 Financial Results and Provides Business Update
4:15pm
8-K
uy5a1i7
1 Mar 22
Rigel Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
4:10pm
8-K
lt4bh bjm
17 Feb 22
Entry into a Material Definitive Agreement
4:30pm
8-K
hve 3ceb2
28 Jan 22
Departure of Directors or Certain Officers
4:05pm
8-K
ff1nmx
10 Jan 22
Rigel Pharmaceuticals Provides Business Update
8:40am
8-K
5c9kqjsulc8g
17 Dec 21
Departure of Directors or Certain Officers
4:40pm
8-K
wglyf0qtl5xzcd
15 Nov 21
Cost Associated with Exit or Disposal Activities
9:00am
8-K
isjkfzqwda5wrfa 0vvc
2 Nov 21
Rigel Reports Third Quarter 2021 Financial Results and Provides Business Update
4:05pm
8-K
e5v161edtowpx7o
13 Aug 21
Rigel Pharmaceuticals Provides Update on COVID-19 Program
4:16pm
8-K
s9xh1hu
3 Aug 21
Rigel Reports Second Quarter 2021 Financial Results and Provides Business Update
4:26pm
8-K
7zhg1d 1mav
21 May 21
Departure of Directors or Certain Officers
4:00pm
8-K
jigqit89hf0wamq1y
14 May 21
Departure of Directors or Certain Officers
9:00am
8-K
z3qts ginkd
5 May 21
Rigel Reports First Quarter 2021 Financial Results and Provides Business Update
4:01pm
8-K
xgf061hef514
13 Apr 21
Other Events
5:26pm
8-K
q5ny smhvwa
2 Mar 21
Rigel Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
4:01pm
8-K
b2ko 9g77aw
18 Feb 21
Entry into a Material Definitive Agreement
6:30am